@SouthwestAir I've been flying @SouthwestAir since the beginning&have A-List Preferred status. I am SO disappointed in what Elliott Investment has done to this brand.Bag fees, assigned seats, skyrocketing prices, I can fly to EUROPE for less. Losing loyal customers. #Southwest
@elonmusk @Robertfkenn
Please please reconsider supporting in full support cdc.gov/nvsn/php/current-sit… this is the only active surveillance platform in the US that can tell what viruses are making kids sick - including @elonmusk kids like X. It been around for 25 years
I promise this is not a waste of money, we do not want to fire people. We are all pediatricians that are dedicated to saving the lives of children. Please find it in your heart to fund this in full.
pubmed.ncbi.nlm.nih.gov/3398…
This is a great paper that shows the value of the surveillance system because we were actively enrolling prior to COVID-19. We were able to demonstrate changes in patterns of viruses. This does not rely on clinician testing.
Check out A Matter of Time: Issue One - The Start of a Sci-Fi Epic by Anthony Esper on @Kickstarter kickstarter.com/projects/ama…
"At the Options flu meeting in Australia – with three koalas clinging to my wine glass, just like the trivalent flu vaccine!"
#koalachallenge2024
NATASHA HALASA retweeted
Excited to announce the Biodevelopmental Origins of Lung Disease (BOLD) Center @vumcpeds where original thinkers from across disciplines tackle pressing questions in development and disease @JKropski @MillisBryan @lisa_bastarache @CWrightVandy
sucrelab.org/bold
sucrelab.org/bold - so excited about this new center - and proud of Dr. Jennifer Sucre, the new Director of this center bring all lung researchers together!!!
@sucre_jen @VUMCDiscoveries @vumcpeds @VUMC_ID @vumcpedsres
Very proud of my team @HalasaLab @SpiekerStats @enasbatarseh @zhaddadin8 @LubnaHamdan6 @MichaelGIsonMD @PergamIC
Comparison of Two High-Dose Versus Two Standard-Dose Influenza Vaccines in Adult Allogeneic Hematopoietic Cell Transplant Recipients
✅ Just Accepted
🔓 Open Access
bit.ly/3P0bBiv
So proud of @DanielleARanki1 for leading this paper and the NVSN team!!!
Rhino/enteroviruses persisted among the pediatric population after the start of the #SARSCoV2 pandemic, while there were sharp declines of enveloped viruses (eg RSV, paraflu), 2020-2021. @HalasaLab @DanielleARanki1 @VUMCepi ja.ma/3Yy22Jy
Proud of my co-authors for this important trial in pediatric stem cell recipients showing 2 HD-TIV better than 2 standard flu @ldanzigerisakov @zhaddadin8 @enasbatarseh @LubnaHamdan6 @herdi_ramadan @Pnyx2010 @SpiekerStats @ckitko @VUMChealth @vumcpeds @VUMC_ID
In this trial involving children who had received a hematopoietic-cell transplant, a high-dose trivalent influenza vaccine elicited higher titers to influenza A antigens than a quadrivalent influenza vaccine. nej.md/3itqIU7
The most amazing mentor and physician - and my academic mother
This Post is from an account that no longer exists. Learn more
NATASHA HALASA retweeted
ICYMI, our latest podcast features Drs. Kathryn Edwards & @KeippTalbot of @VUMC_ID sharing the latest info about COVID-19 bivalent vaccine boosters, including how bivalent vaccines are used and differences between the Moderna the Pfizer boosters.
Listen: bit.ly/3RqNSpp
Proud of the diverse speakers - scoring of oral presentations were blinded - majority of oral abstract winners were women! Also - the Chair of @rsv2022 Dr. Ultan Power was deliberate to make sure keynote speakers had gender and geographic balance.
isirv.org/site/images/confer…
NATASHA HALASA retweeted
Our session 8 keynote is @NATBASH15 who will deliver a presentation on RSV Co-Infections: Traditional vs. Newer Platforms for Detection of Pathogens
#RSV2022
NATASHA HALASA retweeted
#Viewpoint: Vaccines protect children from COVID-19 and its complications: buff.ly/3QcD6CQ
@NATBASH15 @VUMChealth
